Print:

In-licensing for Chinese Market

Areas of interests:

Products/Technologies

  • Marketed products
  • Technology platforms: delivery systems & formulation technologies
  • Late-stage development projects (phase II or beyond)
  • Proprietary early-stage compounds/formulations (ready for IND)

Dosage forms: Injectables or Tablets

Therapeutic Areas Drugs
Hepatitis 1.Nucleoside analogues
2.Others: liver protectants, anti-fibrotic drugs, etc.
Cardiovascular 1.Microcirculation
2.Antithrombotic drugs
3.Anti-hypertension drugs
Anti-tumor Small molecule drugs and targeted therapies as tumor angiogenesis inhibitors and tyrosine-kinase inhibitors
Anti-infection 1.Cephalosporins
2.Quinolones

 

      <b id="qq30sab" ><center id="qq30sab" ></center></b>

    1. <code id="qq30sab" ><font id="qq30sab" ></font></code>
      <noframes id="qq30sab" ></noframes><small id="qq30sab" ><input id="qq30sab" ></input></small>
      <label id="qq30sab" ></label><th id="qq30sab" ><output id="qq30sab" ></output></th>

      <object id="qq30sab" ><delect id="qq30sab" ></delect></object>